Skip to main content
. Author manuscript; available in PMC: 2014 Oct 1.
Published in final edited form as: Exp Dermatol. 2013 Oct;22(10):10.1111/exd.12233. doi: 10.1111/exd.12233

Table 2.

Frequency of combination HLA-E and NKG2C genotypes in psoriasis cases and healthy controls.

Genotype Combination Psoriasis Controls P-val OR (95% CI)
HLA-E*01:03/01:03+NKG2C*Pos/Pos 44 (7.76) 53 (11.62) 0.041 0.64 (0.41–0.99)
HLA-E*01:03/01:03+NKG2C*Pos/Del 32 (5.64) 28 (6.14)
HLA-E*01:03/01:03+NKG2C*Del/Del 4 (0.71) 0 (0.00)
HLA-E*01:03/01:01+NKG2C*Pos/Pos 131 (23.10) 136 (29.82) 0.018 0.71 (0.53–0.94)
HLA-E*01:03/01:01+NKG2C*Pos/Del 101 (17.81) 84 (18.42)
HLA-E*01:03/01:01+NKG2C*Del/Del 11 (1.94) 6 (1.32)
HLA-E*01:01/01:01+NKG2C*Pos/Pos 133 (23.46) 95 (20.83)
HLA-E*01:01/01:01+NKG2C*Pos/Del 98 (17.28) 51 (11.18) 0.007 1.66 (1.14–2.44)
HLA-E*01:01/01:01+NKG2C*Del/Del 13 (2.29) 3 (0.66) 0.042 3.54 (0.96–19.48)